China Universal Asset Management Company’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

China Universal Asset Management Company’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,181	Closed	-$28.5K	–	465
2023 Q1	$28.5K	Buy	1,181 +295	+33%	+$3.7K	0.01%	188
2022 Q4	$9.37K	Buy	886 +122	+16%	+$984	﹤0.01%	234
2022 Q3	$3K	Buy	+764	New	+$3.48K	﹤0.01%	343

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

China Universal Asset Management Company's PRVB Position: Q2 2023 in Review

China Universal Asset Management Company sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,181 shares — an estimated $28.5K sold.

China Universal Asset Management Company first reported a position in PRVB in Q3 2022 and held it in 3 quarters. The position peaked at $28.5K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

China Universal Asset Management Company reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
China Universal Asset Management Company sold 1,181 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $28.5K.
China Universal Asset Management Company first reported a position in Provention Bio, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
China Universal Asset Management Company's Provention Bio, Inc. Common Stock position peaked at $28.5K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on China Universal Asset Management Company's 13F filing for Q2 2023, filed 28 Jul 2023.